Brent Zanke, MD, FRCPC, PhD

Executive-in-Residence

Dr. Brent Zanke consults widely on matters of biomarkers, laboratory molecular pathology, innovation policy and health care delivery systems. He is a graduate of the Universities of Manitoba (MD, 1983) and Toronto (PhD 1993) and a Fellow of the Royal College of Physicians of Canada with speciality certification in internal medicine and medical oncology.  He conducted basic and translational laboratory-based research at the Ontario Cancer Institute before assuming administrative duties as Director of the Cross Cancer Institute in Edmonton, one of Canada’s two free standing cancer hospitals. From 2002 until 2006, he was the Provincial Head of Systemic Therapy for Cancer Care Ontario.  Dr. Zanke is founder and Chairman of ArcticDx, a Canadian private molecular diagnostics company where he also fills the role of Chief Medical Officer since 2008. ArcticDx is a company involved in developing genetic tests that predict future disease, drug toxicity and the efficacy of existing therapies for a variety of diseases. He has helped raised over $10M of venture financing for Arctic and has grown the business to become a profitable international reference laboratory with operations in Canada, America, India and throughout South America. 

Brent-Zanke-img

Other Team Members

Robert M. Sutherland, BSc, PhD

Senior Investment Advisor
Bob-Sutherland-img

Frank Gleeson, BBA, MBA

Executive-in-Residence
Frank-Gleeson-img